These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Role of grandaxin in the treatment of functional gastrointestinal diseases]. Osipenko MF; Khramov IuA; Makarova TA; Vdovenko EG Ter Arkh; 2000; 72(10):23-7. PubMed ID: 11220871 [TBL] [Abstract][Full Text] [Related]
23. [Depression after first myocardial infarction. A prospective study on incidence, prognosis, risk factors and treatment]. Strik JJ; van Praag HM; Honig A Tijdschr Gerontol Geriatr; 2003 Jun; 34(3):104-12. PubMed ID: 12866252 [TBL] [Abstract][Full Text] [Related]
24. [Pharmacologic correction of psycho-emotional status of patients with thyroid nodules in the preoperative period]. Zvukova EM; Marasanov SB; Mokhov EM Vopr Onkol; 2010; 56(6):722-5. PubMed ID: 21395133 [No Abstract] [Full Text] [Related]
25. Anxiolytic medication use is not associated with anxiety level and does not reduce complications after acute myocardial infarction. Abed MA; Frazier S; Hall LA; Moser DK J Clin Nurs; 2013 Jun; 22(11-12):1559-68. PubMed ID: 23311616 [TBL] [Abstract][Full Text] [Related]
27. Management of emotional disorders, anxiety and depression, in patients with gastrointestinal disease. Kasich AM Curr Ther Res Clin Exp; 1965 Sep; 7(9):542-7. PubMed ID: 4953854 [No Abstract] [Full Text] [Related]
28. Diagnosis and treatment of mixed anxiety-depression in the elderly. Crook T J Clin Psychiatry; 1982 Sep; 43(9 Pt 2):35-43. PubMed ID: 6127335 [No Abstract] [Full Text] [Related]
29. [Chronobiological similarity of the specific activity of anxiolytic and antidepressant drugs]. Arushanian EB; Beĭer EV Eksp Klin Farmakol; 2007; 70(5):52-8. PubMed ID: 18074809 [TBL] [Abstract][Full Text] [Related]
30. Depression and anxiety outcomes at a free clinic in a rural state. Burman ME; Petrie J J Am Acad Nurse Pract; 2008 Jul; 20(7):359-66. PubMed ID: 18638175 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacological treatment of depression after acute myocardial infarction]. Fasullo S; Puccio D; Fasullo S; Novo S Ital Heart J Suppl; 2004 Nov; 5(11):839-46. PubMed ID: 15633427 [TBL] [Abstract][Full Text] [Related]
35. [Injectable temesta, anxiety and distress]. Breulet M; Parent M; Bourdouxhe S; Bobon J Acta Psychiatr Belg; 1974 May; 74(3):278-93. PubMed ID: 4156148 [No Abstract] [Full Text] [Related]
36. Brief report: citalopram in child and adolescent depression with anxiety. Schaller JL; Behar D MedGenMed; 2001 Oct; 3(5):1. PubMed ID: 11698908 [No Abstract] [Full Text] [Related]
37. [Persistent insomnia in a depressed athlete]. Suomela T; Henriksson M Duodecim; 2001; 117(2):177-8. PubMed ID: 12092369 [No Abstract] [Full Text] [Related]
38. A cross-sectional examination of changes in anxiety early after acute myocardial infarction. An K; De Jong MJ; Riegel BJ; McKinley S; Garvin BJ; Doering LV; Moser DK Heart Lung; 2004; 33(2):75-82. PubMed ID: 15024372 [TBL] [Abstract][Full Text] [Related]
39. Management of mixed anxiety and depression. Degruy F Am Fam Physician; 1994 Mar; 49(4):860-6. PubMed ID: 7906917 [TBL] [Abstract][Full Text] [Related]
40. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]